in May 2013 the authoritative publication "Forbes" interviewed the founder of the company "Nervostrong Medica". "Forbes" appreciated the fact that in a relatively short time - three years - a pharmaceutical company was established, which with only three products achieved a turnover exceeding € 1 000 000, but the main players in the drug market have gained the opportunity to earn more than in the last five years € 5 000 000. Moreover, this result was achieved in the relatively small Latvian pharmaceutical market.